European Opportunities Loom For Value Added Medicines

But Sales Still Lag US, With EU Legislative Review Set To Address Sector’s Need For Reform

 
• By Dave Wallace
  
Medicines for Europe 5th Value Added Medicines conference panel
Panelists discussed opportunities and obstacles for value added medicines at Medicines for Europe’s fifth annual conference • Source: Medicines for Europe
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography